Alzheimer’s disease Classification from Brain MRI based on transfer learning from CNN

2018 ◽  
Author(s):  
Bijen Khagi ◽  
Chung Ghiu Lee ◽  
Goo-Rak Kwon
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Transfer Learning ◽  
Brain Mri ◽  
Disease Classification

scholarly journals A Comparative Study of Alzheimer’s Disease Classification using Multiple Transfer Learning Models

2019 ◽  
Vol 6 (4) ◽  
pp. 209-216
Author(s):  
Deekshitha Prakash ◽  
Nuwan Madusanka ◽  
Subrata Bhattacharjee ◽  
Hyeon-Gyun Park ◽  
Cho-Hee Kim ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Comparative Study ◽  
Transfer Learning ◽  
Disease Classification ◽  
Learning Models

scholarly journals Classification of Sex and Alzheimer’s Disease via Brain Imaging-Based Deep Learning on 85,721 Samples

2020 ◽  
Author(s):  
Bin Lu ◽  
Hui-Xian Li ◽  
Zhi-Kai Chang ◽  
Le Li ◽  
Ning-Xuan Chen ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Deep Learning ◽  
Individual Differences ◽  
Brain Imaging ◽  
Transfer Learning ◽  
Brain Mri ◽  
Classification Model ◽  
Parahippocampal Gyrus ◽  
Industrial Grade

AbstractBeyond detecting brain damage or tumors, little success has been attained on identifying individual differences and brain disorders with magnetic resonance imaging (MRI). Here, we sought to build industrial-grade brain imaging-based classifiers to infer two types of such inter-individual differences: sex and Alzheimer’s disease (AD), using deep learning/transfer learning on big data. We pooled brain structural data from 217 sites/scanners to constitute the largest brain MRI sample to date (85,721 samples from 50,876 participants), and applied a state-of-the-art deep convolutional neural network, Inception-ResNet-V2, to build a sex classifier with high generalizability. In cross-dataset-validation, the sex classification model was able to classify the sex of any participant with brain structural imaging data from any scanner with 94.9% accuracy. We then applied transfer learning based on this model to objectively diagnose AD, achieving 88.4% accuracy in cross-site-validation on the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset and 91.2% / 86.1% accuracy for a direct test on two unseen independent datasets (AIBL / OASIS). Directly testing this AD classifier on brain images of unseen mild cognitive impairment (MCI) patients, the model correctly predicted 63.2% who eventually converted into AD, versus predicting 22.1% as AD who did not convert into AD during follow-up. Predicted scores of the AD classifier correlated significantly with illness severity. By contrast, the transfer learning framework was unable to achieve practical accuracy for psychiatric disorders. To improve interpretability of the deep learning models, occlusion tests revealed that hypothalamus, superior vermis, thalamus, amygdala and limbic system areas were critical for predicting sex; hippocampus, parahippocampal gyrus, putamen and insula played key roles in predicting AD. Our trained model, code, preprocessed data and an online prediction website have been openly-shared to advance the clinical utility of brain imaging.

scholarly journals Alzheimer’s Disease: Classification and Detection using MRI Dataset

2021 ◽  
Vol 10 (5) ◽  
pp. 70-72
Author(s):  
V P Suhaira ◽  
Sita S ◽  
Joby George
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Heart Function ◽  
Brain Mri ◽  
Memory Loss ◽  
Disease Classification ◽  
Data Set ◽  
Mri Scans ◽  
Disease Experience ◽  
The Brain

Alzheimer's disease (AD) is a hereditary brain condition that is incurable and progresses over time. Patients with Alzheimer's disease experience memory loss, uncertainty, and difficulty speaking, reading, and writing as a result of this condition. Alzheimer's disease eventually affects the portion of the brain that controls breathing and heart function, leading to death. This framework proposes the OASIS (Open Access Series of Imaging Studies) dataset, which contains the existing MRI data set, which is comprised of a longitudinal sample of 150 subjects aged 60 to 96 who were all acquired on the same scanner using similar sequences. This paper uses a combination of brain MRI scans and psychological parameters to predict disease with high accuracy using various classifier algorithms, and the results can be compared to improve performance.

scholarly journals Alzheimer's Disease Classification Accuracy is Improved by MRI Harmonization based on Attention-Guided Generative Adversarial Networks

2021 ◽  
Author(s):  
surabhi sinha ◽  
Sophia I. Thomopoulos ◽  
Pradeep Lam ◽  
Alexandra Muir ◽  
Paul M. Thompson
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Domain Adaptation ◽  
Imaging Techniques ◽  
Brain Mri ◽  
Memory Loss ◽  
Disease Classification ◽  
Generative Adversarial Networks ◽  
Generative Adversarial Network ◽  
Adversarial Network

Alzheimer's disease (AD) accounts for 60% of dementia cases worldwide; patients with the disease typically suffer from irreversible memory loss and progressive decline in multiple cognitive domains. With brain imaging techniques such as magnetic resonance imaging (MRI), microscopic brain changes are detectable even before abnormal memory loss is detected clinically. Patterns of brain atrophy can be measured using MRI, which gives us an opportunity to facilitate AD detection using image classification techniques. Even so, MRI scanning protocols and scanners differ across studies. The resulting differences in image contrast and signal to noise make it important to train and test classification models on multiple datasets, and to handle shifts in image characteristics across protocols (also known as domain transfer or domain adaptation). Here, we examined whether adversarial domain adaptation can boost the performance of a Convolutional Neural Network (CNN) model designed to classify AD. To test this, we used an Attention-Guided Generative Adversarial Network (GAN) to harmonize images from three publicly available brain MRI datasets - ADNI, AIBL and OASIS - adjusting for scanner-dependent effects. Our AG-GAN optimized a joint objective function that included attention loss, pixel loss, cycle-consistency loss and adversarial loss; the model was trained bidirectionally in an end-to-end fashion. For AD classification, we adapted the popular 2D AlexNet CNN to handle 3D images. Classification based on harmonized MR images significantly outperformed classification based on the three datasets in non-harmonized form, motivating further work on image harmonization using adversarial techniques.

scholarly journals A Practical Alzheimer Disease Classifier via Brain Imaging-Based Deep Learning on 85,721 Samples

2021 ◽  
Author(s):  
Bin Lu ◽  
Hui-Xian Li ◽  
Zhi-Kai Chang ◽  
Le Li ◽  
Ning-Xuan Chen ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Deep Learning ◽  
Transfer Learning ◽  
Brain Mri ◽  
Machine Learning Algorithms ◽  
Training Data ◽  
Generalization Capability ◽  
Brain Images ◽  
Magnetic Resonance Imaging Mri

Abstract BackgroundBeyond detecting brain lesions or tumors, comparatively little success has been attained in identifying brain disorders such as Alzheimer’s disease (AD), based on magnetic resonance imaging (MRI). Many machine learning algorithms to detect AD have been trained using limited training data, meaning they often generalize poorly when applied to scans from previously unseen populations. Therefore, we built a practical brain MRI-based AD diagnostic classifier using deep learning/transfer learning on dataset of unprecedented size and diversity. MethodsA retrospective MRI dataset pooled from more than 217 sites/scanners constituted the largest brain MRI sample to date (85,721 scans from 50,876 participants) between January 2017 and August 2021. Next, a state-of-the-art deep convolutional neural network, Inception-ResNet-V2, was built as a sex classifier with high generalization capability. The sex classifier achieved 94.9% accuracy and served as a base model in transfer learning for the objective diagnosis of AD. FindingsAfter transfer learning, the model fine-tuned for AD classification achieved 91.3% accuracy in leave-sites-out cross-validation on the Alzheimer's Disease Neuroimaging Initiative (ADNI, 6,857 samples) dataset and 94.2%/93.6%/90.5% accuracy for direct tests on three unseen independent datasets (AIBL, 669 samples / MIRIAD, 644 samples / OASIS, 1,123 samples). When this AD classifier was tested on brain images from unseen mild cognitive impairment (MCI) patients, MCI patients who finally converted to AD were 3 times more likely to be predicted as AD than MCI patients who did not convert (65.2% vs 20.6%). Predicted scores from the AD classifier showed significant correlations with illness severity. InterpretationIn sum, the proposed AD classifier could offer a medical-grade marker that have potential to be integrated into AD diagnostic practice.

Sign in / Sign up

Export Citation Format

Share Document